Healthpeak Properties Announces Leadership Changes in Lab Investments and Development.
PorAinvest
miércoles, 27 de agosto de 2025, 7:08 am ET1 min de lectura
DOC--
Denis Sullivan brings over two decades of experience in life science real estate, having previously served as Chief Investment Officer and Chief Financial Officer at BioMed Realty. He also co-founded Foundation Capital Ventures, where he helped develop life science properties in leading innovation hubs. Under his new role, Sullivan will drive Healthpeak's portfolio-wide Lab investment strategy and oversee leasing and asset management activities in San Diego, a key market for life science innovation [1].
Mike Dorris, who has been promoted to Head of West Coast Development & Construction for Lab, will expand Healthpeak's expertise in specialized lab design and construction. This move will enhance the company's development and redevelopment capabilities, ensuring it continues to create state-of-the-art spaces for medical breakthroughs [1].
These appointments reflect Healthpeak's commitment to the life science sector and its strategy to capture investment and leasing opportunities as the market recovers. The company aims to leverage Sullivan's investment leadership and Dorris's technical expertise to strengthen its platform from sourcing opportunities to delivering innovative solutions for tenants [1].
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company, specializing in high-quality real estate focused on healthcare discovery and delivery. For more information, visit www.healthpeak.com [1].
References:
[1] https://www.stocktitan.net/news/DOC/healthpeak-strengthens-life-science-leadership-with-addition-of-44scybfc3w6r.html
Healthpeak Properties has announced two executive changes: Denis Sullivan joins as Managing Director of Lab Investments & San Diego Market Lead, and Mike Dorris is promoted to Head of West Coast Development & Construction. Sullivan brings 20 years of life science real estate leadership experience, and Dorris will expand Healthpeak's lab design and construction capabilities. The moves position Healthpeak to capture investment and leasing opportunities as the life science market recovers.
Healthpeak Properties, Inc. (NYSE: DOC) has announced significant executive changes aimed at strengthening its position in the life science real estate sector. Denis Sullivan has joined the company as Managing Director of Lab Investments & San Diego Market Lead, while Mike Dorris has been promoted to Head of West Coast Development & Construction [1].Denis Sullivan brings over two decades of experience in life science real estate, having previously served as Chief Investment Officer and Chief Financial Officer at BioMed Realty. He also co-founded Foundation Capital Ventures, where he helped develop life science properties in leading innovation hubs. Under his new role, Sullivan will drive Healthpeak's portfolio-wide Lab investment strategy and oversee leasing and asset management activities in San Diego, a key market for life science innovation [1].
Mike Dorris, who has been promoted to Head of West Coast Development & Construction for Lab, will expand Healthpeak's expertise in specialized lab design and construction. This move will enhance the company's development and redevelopment capabilities, ensuring it continues to create state-of-the-art spaces for medical breakthroughs [1].
These appointments reflect Healthpeak's commitment to the life science sector and its strategy to capture investment and leasing opportunities as the market recovers. The company aims to leverage Sullivan's investment leadership and Dorris's technical expertise to strengthen its platform from sourcing opportunities to delivering innovative solutions for tenants [1].
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company, specializing in high-quality real estate focused on healthcare discovery and delivery. For more information, visit www.healthpeak.com [1].
References:
[1] https://www.stocktitan.net/news/DOC/healthpeak-strengthens-life-science-leadership-with-addition-of-44scybfc3w6r.html
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios